Advantages
- Collaboration opportunity with a laboratory with expertise in vascular pain evaluation and with extensive pain evaluation experience
- “Vascular pain” is unmet need in the care of patients and a highly occurring complication in cancer chemotherapy that is expected to expand in the market
Background and Technology
Vascular pain is a phenomenon that occurs with the administration of anticancer therapies and intravenous infusions with high osmotic pressure. Some are caused by the anticancer drugs themselves, such as oxaliplatin, doxorubicin, daunorubicin, amrubicin, idarubicin, vinorelbine, epirubicin, gemcitabine, and fluorouracil, and There have been reports of the development of vascular pain caused by such drugs. In addition, vascular pain caused by phlebitis is a challenge due to the onset of infusion of antibiotics and high sugar concentrations.
A survey conducted at Fukuoka University Hospital revealed that 57.7% of patients complained of vascular pain during treatment with CAPEOX (oxaliplatin-capecitabine combination therapy) + BV (bevacizumab). Although the infusion site is heated and the pH of the solution is adjusted during chemotherapy, many patients still suffer from the complication of vascular pain during treatment.
As a result, the inventor found a problem in the dressing material that fixes the indwelling needle of intravenous drips and catheters and came to propose a dressing material focusing on the improvement of (1) “prevention of skin and blood vessel compression” by fixing the indwelling needle on the skin and (2) “securing blood flow” from the periphery. We have proposed a dressing that focuses on (1) preventing skin and blood vessel compression by securing the indwelling needle to the skin and (2) securing blood flow from the periphery. We have confirmed that the method of fixing the indwelling needle without compressing the vein by using this dressing did not cause vascular pain in patients who had previously had vascular pain.
![]() |
Patent
JP granted
Applicant
Fukuoka University
Researcher
Fukuoka University Hospital Medical informatics&Digital Medicine Professor (Digestive Surgery Specialty)
Yoichiro Yoshida
Development Phase
Current stage:
Completed the structural and conceptual design of this dressing material and the performance demonstration.
Next stage:
1) Creation of dressings that can be mass-produced using optimal materials.
2) Clinical evaluation
We are looking for partner companies to collaborate on the above development and commercialization.
We would be happy to start with a detailed explanation and discussion of the technology.
Project No.ON-05186